Possible role of tryptophan and melatonin in COVID-19
Open Access
- 1 January 2020
- journal article
- editorial
- Published by SAGE Publications in International Journal of Tryptophan Research
- Vol. 13
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Therapeutic management of patients with COVID-19: a systematic reviewInfection Prevention in Practice, 2020
- Coronaviruses and SARS-COV-2TURKISH JOURNAL OF MEDICAL SCIENCES, 2020
- Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depressionBrain, Behavior, and Immunity, 2020
- Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular OutcomesAnnals of Internal Medicine, 2019
- Microbiota Alterations in Alzheimer’s Disease: Involvement of the Kynurenine Pathway and InflammationNeurotoxicity Research, 2019
- Microorganisms, Tryptophan Metabolism, and Kynurenine Pathway: A Complex Interconnected Loop Influencing Human Health StatusInternational Journal of Tryptophan Research, 2019
- Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetesJCI Insight, 2018
- The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune DiabetesFrontiers in Immunology, 2017
- Melatonin: Buffering the Immune SystemInternational Journal of Molecular Sciences, 2013
- SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisProceedings of the National Academy of Sciences, 2008